Aehr Test Systems(NASDAQ:AEHR) 
Aehr Test Systems primarily designs, engineers, manufactures, and sells test and burn-in equipment for use in the semiconductor industry in the United States, Asia, and Europe. It provides full wafer contact test systems, test during burn-in systems, test fixtures, and related accessories. The compa...
Website: http://www.aehr.com
Founded: 1977
Full Time Employees: 71
Founder: Rhea J. Posedel
CEO: Gayn Erickson
Sector: Technology
Industry: Semiconductor Equipment & Materials
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
- Exposure to Silicon Carbide (SiC) Device Testing Demand: Aehr’s revenue outlook is closely tied to adoption of SiC power semiconductors in electric vehicles, charging infrastructure, and industrial applications, which can drive demand for high-volume burn-in and test solutions.
- Customer Concentration and Order Timing Can Drive Volatility: Results can swing meaningfully based on the timing of large customer orders and shipment schedules, with customer concentration making quarterly revenue and profitability less predictable.
- Platform and Consumables Mix Influences Margins: Gross margin and earnings can vary depending on the mix between system sales and higher-margin consumables/wafer contactor-related revenue, along with production scale and utilization.
- Scaling Operations to Meet Demand While Managing Execution Risk: As demand ramps, the company’s ability to manage supply chain, manufacturing throughput, and product delivery timelines is key to converting backlog/pipeline into revenue without margin erosion.
Bull Thesis:
- Dominant Position in Silicon Carbide (SiC) Burn-in: Aehr Test Systems holds a leading position in the critical full wafer contact burn-in and test market for Silicon Carbide (SiC) power semiconductors. As SiC adoption accelerates in electric vehicles (EVs), renewable energy, and industrial applications, AEHR is uniquely positioned to benefit from the increasing demand for reliable SiC devices, which require extensive burn-in.
- Long-term SiC Market Growth Trajectory: Despite short-term fluctuations in customer orders, the long-term outlook for the SiC market remains robust. Industry analysts project significant growth in SiC demand over the next decade, driven by the global transition to EVs and the need for more efficient power electronics. AEHR's technology is essential for ensuring the quality and reliability of these high-value components, providing a sustained tailwind for the company.
- Expanding Market Opportunities Beyond SiC: While SiC is a primary driver, AEHR's proprietary FOX-P™ and ABT™ systems are also applicable to other high-growth markets, including silicon photonics for AI/data centers, memory, and other advanced semiconductor devices. This diversification provides additional revenue streams and reduces reliance on a single market segment, opening new avenues for growth as these technologies mature.
- Strong IP and Technological Advantage: Aehr possesses strong intellectual property and a technological advantage with its full wafer contact parallel test and burn-in solutions. This technology offers significant cost and efficiency benefits for high-volume production compared to traditional methods, making it a preferred choice for leading semiconductor manufacturers and creating a competitive moat.
Bear Thesis:
- Significant Customer Concentration Risk: A substantial portion of Aehr's revenue has historically come from a few large customers, particularly a major SiC manufacturer. Delays, reduced capital expenditures, or changes in production plans from these key customers can lead to significant revenue volatility and missed financial targets, as seen in recent quarters.
- Lumpy Order Flow and Revenue Volatility: As a capital equipment provider, AEHR's revenue is inherently lumpy, driven by large, infrequent orders rather than consistent, recurring sales. This makes forecasting challenging and can lead to significant quarter-over-quarter fluctuations in financial performance, making the stock susceptible to sharp movements based on order announcements or lack thereof.
- Macroeconomic Headwinds and EV Market Slowdown: A broader economic slowdown, rising interest rates, or a deceleration in the adoption rate of electric vehicles could negatively impact demand for SiC power semiconductors. This, in turn, would reduce the need for AEHR's test and burn-in equipment, affecting future order intake and revenue growth.
- Inventory Build-up and Potential Write-downs: Aehr has been building inventory in anticipation of future orders, particularly for its FOX-P systems. If these anticipated orders do not materialize as expected or are significantly delayed, the company could face risks of inventory obsolescence, write-downs, and negative impacts on cash flow and profitability.
Main Competitors:
- Teradyne ($TER) (FLEX, J750, UltraFLEX, Magnum, ETS platforms (various ATE systems)), Teradyne is a leading global supplier of automatic test equipment (ATE) for semiconductors, system test, and wireless products. While Aehr specializes in full wafer contact burn-in, Teradyne competes for the overall semiconductor test budget, offering a broad range of testers for power devices, mixed-signal, and memory, which can be alternative or complementary solutions to Aehr's offerings for certain test phases and device types.
- Advantest Corporation ($ATEYY) (V93000, T2000, T5800 series (various ATE systems)), Advantest is another major global provider of ATE, offering solutions for SoC, memory, and power semiconductor testing. Similar to Teradyne, Advantest competes with Aehr for semiconductor manufacturers' capital expenditure on test equipment, providing alternative test methodologies and systems for devices that Aehr's full wafer contact burn-in systems target, particularly in the power and memory segments.
- Cohu, Inc. ($COHU) (Diamondx, Eclipse, cDragon (test handlers), various contactors and thermal solutions), Cohu provides back-end semiconductor equipment, including test handlers, contactors, and thermal subsystems. While Aehr focuses on the test and burn-in system itself (especially full wafer contact), Cohu's products are integral to the overall test cell. Cohu competes by offering integrated test solutions and components that can be used with various testers, including those for power devices, potentially offering different approaches to the overall test and burn-in process or competing for the same capital expenditure in the back-end.
Moat:
Aehr Test Systems operates in a specialized niche within the semiconductor test equipment market, primarily focusing on full wafer contact burn-in and test solutions, with a strong emphasis on silicon carbide (SiC) power semiconductors, photonics, and memory. Its primary moat lies in its proprietary FOX™ platform, which enables highly efficient, parallel full wafer contact burn-in, a capability not widely replicated by larger, more general Automatic Test Equipment (ATE) providers. This technology offers significant cost and time savings for high-volume production, particularly for critical components like those used in electric vehicles and data centers. Competition comes from several angles: broad ATE providers (like Teradyne and Advantest) who offer alternative test methodologies and compete for overall test budgets; back-end equipment providers (like Cohu) who offer complementary or integrated solutions for the test cell; and to a lesser extent, in-house solutions developed by large semiconductor manufacturers. Aehr's competitive advantage is its unique technology for high-volume, cost-effective full wafer burn-in, especially in the rapidly growing SiC market, strengthened by its intellectual property and early market penetration in this specific, high-growth segment.
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-02-27 | 2025-11-28 | 2025-08-29 | 2025-05-30 | 2025-02-28 | 2024-11-29 | 2024-08-30 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | 2019-11-30 | 2019-08-31 | 2019-05-31 | 2019-02-28 | 2018-11-30 | 2018-08-31 | 2018-05-31 | 2018-02-28 | 2017-11-30 | 2017-08-31 | 2017-05-31 | 2017-02-28 | 2016-11-30 | 2016-08-31 | 2016-05-31 | 2016-05-30 | 2016-02-29 | 2015-11-30 | 2015-08-31 | 2015-05-31 | 2015-02-28 | 2014-11-30 | 2014-08-31 | 2014-05-31 | 2014-02-28 | 2013-11-30 | 2013-08-31 | 2013-05-31 | 2013-02-28 | 2012-11-30 | 2012-08-31 | 2012-05-31 | 2012-02-29 | 2011-11-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
total revenue | 10,313,000 | 9,884,000 | 10,969,000 | 14,089,000 | 18,307,000 | 13,453,000 | 13,119,000 | 16,600,000 | 7,563,000 | 21,431,000 | 20,624,000 | 22,269,000 | 17,206,000 | 14,815,000 | 10,671,000 | 20,289,000 | 15,283,000 | 9,611,000 | 5,646,000 | 7,638,000 | 5,267,000 | 1,683,000 | 2,012,000 | 3,773,000 | 6,111,000 | 6,874,000 | 5,533,000 | 7,242,000 | 3,163,000 | 5,911,000 | 4,740,000 | 7,269,000 | 7,393,000 | 7,923,000 | 6,970,000 | 6,683,000 | 2,681,000 | 4,216,000 | 5,318,000 | 1,571,000 | 1,677,000 | 4,620,000 | 6,633,000 | 1,818,000 | 2,027,000 | 2,615,000 | 3,558,000 | 5,370,000 | 5,612,000 | 4,950,000 | 3,752,000 | 3,306,500 | 3,340,000 | 5,054,000 | 4,832,000 | 2,711,250 | 2,855,000 | 3,860,000 | |
yoy | -43.67% | -26.53% | -16.39% | -15.13% | 142.06% | -37.23% | -36.39% | -25.46% | -56.04% | 44.66% | 93.27% | 9.76% | 12.58% | 54.15% | 89.00% | 165.63% | 190.17% | 471.06% | 180.62% | 102.44% | -13.81% | -75.52% | -63.64% | -47.90% | 93.20% | 16.29% | 16.73% | -0.37% | -57.22% | -25.39% | -31.99% | 8.77% | 175.76% | 87.93% | 31.06% | 70.66% | 151.40% | 15.11% | -13.59% | -17.27% | 76.67% | 86.42% | -66.15% | -63.88% | -47.17% | -5.17% | 62.41% | 68.02% | -2.06% | -22.35% | 21.95% | 16.99% | 30.93% | ||||||
qoq | 4.34% | -9.89% | -22.14% | -23.04% | 36.08% | 2.55% | -20.97% | 119.49% | -64.71% | 3.91% | -7.39% | 29.43% | 16.14% | 38.83% | -47.40% | 32.76% | 59.02% | 70.23% | -26.08% | 45.02% | 212.95% | -16.35% | -46.67% | -38.26% | -11.10% | 24.24% | -23.60% | 128.96% | -46.49% | 24.70% | -34.79% | -1.68% | -6.69% | 13.67% | 4.29% | 149.27% | -36.41% | -20.72% | -6.32% | -63.70% | -30.35% | 264.85% | -10.31% | -22.49% | -26.50% | -33.74% | -4.31% | 13.37% | 31.93% | 13.47% | -1.00% | -33.91% | 4.59% | 78.22% | -5.04% | -26.04% | |||
total cost of revenue | 6,945,000 | 7,339,000 | 7,250,000 | 9,817,000 | 11,124,000 | 8,053,000 | 6,041,000 | 8,152,000 | 4,407,000 | 10,473,000 | 10,643,000 | 10,790,000 | 8,331,000 | 6,904,000 | 6,190,000 | 9,821,000 | 8,886,000 | 5,092,000 | 3,365,000 | 4,104,000 | 3,373,000 | 1,306,000 | 1,785,000 | 3,866,000 | 3,120,000 | 3,672,000 | 3,262,000 | 3,863,000 | 2,891,000 | 3,513,000 | 3,187,000 | 4,108,000 | 4,217,000 | 4,792,000 | 4,052,000 | 4,075,000 | 2,178,000 | 2,753,000 | 3,112,000 | 1,669,000 | 1,508,000 | 2,929,000 | 3,250,000 | 1,136,000 | 1,175,000 | 1,921,000 | 1,948,000 | 2,456,000 | 2,742,000 | 2,456,000 | 1,808,000 | 1,970,000 | 2,575,000 | 2,791,000 | 2,376,000 | 2,507,000 | 1,747,000 | 2,732,000 | |
gross profit | 3,368,000 | 2,545,000 | 3,719,000 | 4,272,000 | 7,183,000 | 5,400,000 | 7,078,000 | 8,448,000 | 3,156,000 | 10,958,000 | 9,981,000 | 11,479,000 | 8,875,000 | 7,911,000 | 4,481,000 | 10,468,000 | 6,397,000 | 4,519,000 | 2,281,000 | 3,534,000 | 1,894,000 | 377,000 | 227,000 | -93,000 | 2,991,000 | 3,202,000 | 2,271,000 | 3,379,000 | 272,000 | 2,398,000 | 1,553,000 | 3,161,000 | 3,176,000 | 3,131,000 | 2,918,000 | 2,608,000 | 503,000 | 1,463,000 | 2,206,000 | -98,000 | 169,000 | 1,691,000 | 3,383,000 | 682,000 | 852,000 | 694,000 | 1,610,000 | 2,914,000 | 2,870,000 | 2,494,000 | 1,944,000 | 1,292,000 | 765,000 | 2,263,000 | 2,456,000 | 2,169,000 | 1,108,000 | 1,128,000 | |
yoy | -53.11% | -52.87% | -47.46% | -49.43% | 127.60% | -50.72% | -29.09% | -26.40% | -64.44% | 38.52% | 122.74% | 9.66% | 38.74% | 75.06% | 96.45% | 196.21% | 237.75% | 1098.67% | 904.85% | -3900.00% | -36.68% | -88.23% | -90.00% | -102.75% | 999.63% | 33.53% | 46.23% | 6.90% | -91.44% | -23.41% | -46.78% | 21.20% | 531.41% | 114.01% | 32.28% | -613.27% | 765.68% | 30.46% | -114.37% | -80.16% | 143.66% | 110.12% | -76.60% | -70.31% | -72.17% | -17.18% | 125.54% | 275.16% | 10.21% | -20.85% | -40.43% | -30.96% | 100.62% | ||||||
qoq | 32.34% | -31.57% | -12.94% | -40.53% | 33.02% | -23.71% | -16.22% | 167.68% | -71.20% | 9.79% | -13.05% | 29.34% | 12.19% | 76.55% | -57.19% | 63.64% | 41.56% | 98.11% | -35.46% | 86.59% | 402.39% | 66.08% | -344.09% | -103.11% | -6.59% | 41.00% | -32.79% | 1142.28% | -88.66% | 54.41% | -50.87% | -0.47% | 1.44% | 7.30% | 11.89% | 418.49% | -65.62% | -33.68% | -157.99% | -90.01% | -50.01% | 396.04% | -19.95% | 22.77% | -56.89% | -44.75% | 1.53% | 15.08% | 28.29% | 50.46% | 68.89% | -66.20% | -7.86% | 13.23% | 95.76% | -1.77% | |||
gross margin % | 32.66% | 25.75% | 33.90% | 30.32% | 39.24% | 40.14% | 53.95% | 50.89% | 41.73% | 51.13% | 48.40% | 51.55% | 51.58% | 53.40% | 41.99% | 51.59% | 41.86% | 47.02% | 40.40% | 46.27% | 35.96% | 22.40% | 11.28% | -2.46% | 48.94% | 46.58% | 41.04% | 46.66% | 8.60% | 40.57% | 32.76% | 43.49% | 42.96% | 39.52% | 41.87% | 39.02% | 18.76% | 34.70% | 41.48% | -6.24% | 10.08% | 36.60% | 51.00% | 37.51% | 42.03% | 26.54% | 45.25% | 54.26% | 51.14% | 50.38% | 51.81% | 39.07% | 22.90% | 44.78% | 50.83% | 80.00% | 38.81% | 29.22% | |
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
research and development | 3,167,000 | 2,972,000 | 2,849,000 | 2,686,000 | 3,140,000 | 2,276,000 | 2,361,000 | 2,151,000 | 2,139,000 | 1,972,000 | 2,457,000 | 2,253,000 | 1,832,000 | 1,551,000 | 1,498,000 | 1,655,000 | 1,529,000 | 1,313,000 | 1,321,000 | 1,029,000 | 903,000 | 820,000 | 900,000 | 854,000 | 845,000 | 795,000 | 892,000 | 1,120,000 | 931,000 | 986,000 | 1,116,000 | 1,096,000 | 1,040,000 | 1,090,000 | 955,000 | 1,309,000 | 1,248,000 | 1,040,000 | 1,060,000 | 1,046,000 | 1,293,000 | 923,000 | 1,062,000 | 967,000 | 1,031,000 | 1,105,000 | 959,000 | 1,016,000 | 907,000 | 798,000 | 681,000 | 634,000 | 685,000 | 962,000 | 930,000 | 1,134,000 | 933,000 | 1,039,000 | |
selling, general and administrative | 4,430,000 | 4,434,000 | 4,717,000 | 3,926,000 | 5,162,000 | 4,637,000 | 4,558,000 | 3,756,000 | 3,063,000 | 3,518,000 | 3,409,000 | 3,587,000 | 3,250,000 | 2,875,000 | 2,525,000 | 2,993,000 | 2,612,000 | 2,489,000 | 1,953,000 | 1,904,000 | 1,643,000 | 1,501,000 | 1,514,000 | 1,674,000 | 1,891,000 | 2,157,000 | 1,808,000 | 2,018,000 | 1,850,000 | 1,977,000 | 1,879,000 | 1,816,000 | 1,829,000 | 1,854,000 | 1,791,000 | 1,905,000 | 1,724,000 | 1,707,000 | 1,716,000 | 1,722,000 | 1,695,000 | 1,713,000 | 1,845,000 | 1,526,000 | 1,584,000 | 1,736,000 | 1,624,000 | 1,685,000 | 1,701,000 | 1,517,000 | 1,420,000 | 1,504,000 | 1,511,000 | 2,068,000 | 1,789,000 | 1,872,000 | 1,525,000 | 1,528,000 | |
restructuring charges | -213,000 | 219,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating expenses | 7,597,000 | 7,193,000 | 7,785,000 | 7,476,000 | 8,302,000 | 6,913,000 | 6,919,000 | 5,907,000 | 5,202,000 | 5,490,000 | 5,866,000 | 5,840,000 | 5,082,000 | 4,426,000 | 4,023,000 | 4,648,000 | 4,141,000 | 3,802,000 | 3,274,000 | 2,933,000 | 2,546,000 | 2,321,000 | 2,414,000 | 2,748,000 | 2,736,000 | 2,952,000 | 2,700,000 | 3,256,000 | 3,388,000 | 2,963,000 | 2,995,000 | 2,912,000 | 2,869,000 | 2,944,000 | 2,746,000 | 3,214,000 | 2,972,000 | 2,747,000 | 2,776,000 | 2,768,000 | 2,988,000 | 2,636,000 | 2,907,000 | 2,493,000 | 2,615,000 | 2,841,000 | 2,583,000 | 2,701,000 | 2,608,000 | 2,315,000 | 2,101,000 | 2,138,000 | 2,196,000 | 3,030,000 | 2,719,000 | 3,006,000 | 2,458,000 | 2,567,000 | |
income from operations | -4,229,000 | -4,648,000 | -4,066,000 | -3,204,000 | -1,119,000 | -1,513,000 | 159,000 | 2,541,000 | -2,046,000 | 5,468,000 | 4,115,000 | 5,639,000 | 3,793,000 | 3,485,000 | 458,000 | 5,820,000 | 2,256,000 | 717,000 | -993,000 | 601,000 | -652,000 | -1,944,000 | -2,187,000 | -2,841,000 | 255,000 | 250,000 | -429,000 | 123,000 | -3,116,000 | -565,000 | -1,442,000 | 249,000 | 307,000 | 187,000 | 172,000 | -606,000 | -2,469,000 | -1,284,000 | -570,000 | -2,866,000 | -2,819,000 | -945,000 | 476,000 | -1,811,000 | -1,763,000 | -2,147,000 | -973,000 | 213,000 | 262,000 | 179,000 | -157,000 | -846,000 | -1,431,000 | -767,000 | -263,000 | -837,000 | -1,350,000 | -1,439,000 | |
yoy | 277.93% | 207.20% | -2657.23% | -226.09% | -45.31% | -127.67% | -96.14% | -54.94% | -153.94% | 56.90% | 798.47% | -3.11% | 68.13% | 386.05% | -146.12% | 868.39% | -446.01% | -136.88% | -54.60% | -121.15% | -355.69% | -877.60% | 409.79% | -2409.76% | -108.18% | -144.25% | -70.25% | -50.60% | -1114.98% | -402.14% | -938.37% | -141.09% | -112.43% | -114.56% | -130.18% | -13.85% | -54.45% | -39.68% | 58.26% | 59.90% | -55.99% | -148.92% | -950.23% | -772.90% | -1299.44% | 519.75% | -125.18% | -118.31% | -123.34% | -40.30% | 1.08% | 6.00% | -46.70% | ||||||
qoq | -9.01% | 14.31% | 26.90% | 186.33% | -26.04% | -1051.57% | -93.74% | -224.19% | -137.42% | 32.88% | -27.03% | 48.67% | 8.84% | 660.92% | -92.13% | 157.98% | 214.64% | -172.21% | -265.22% | -192.18% | -66.46% | -11.11% | -23.02% | -1214.12% | 2.00% | -158.28% | -448.78% | -103.95% | 451.50% | -60.82% | -679.12% | -18.89% | 64.17% | 8.72% | -128.38% | -75.46% | 92.29% | 125.26% | 1.67% | 198.31% | -298.53% | -126.28% | 2.72% | -17.89% | 120.66% | -556.81% | -18.70% | 46.37% | -214.01% | -81.44% | -40.88% | 86.57% | 191.63% | -68.58% | -38.00% | -6.18% | |||
operating margin % | -41.01% | -47.03% | -37.07% | -22.74% | -6.11% | -11.25% | 1.21% | 15.31% | -27.05% | 25.51% | 19.95% | 25.32% | 22.04% | 23.52% | 4.29% | 28.69% | 14.76% | 7.46% | -17.59% | 7.87% | -12.38% | -115.51% | -108.70% | -75.30% | 4.17% | 3.64% | -7.75% | 1.70% | -98.51% | -9.56% | -30.42% | 3.43% | 4.15% | 2.36% | 2.47% | -9.07% | -92.09% | -30.46% | -10.72% | -182.43% | -168.10% | -20.45% | 7.18% | -99.61% | -86.98% | -82.10% | -27.35% | 3.97% | 4.67% | 3.62% | -4.18% | -25.59% | -42.84% | -15.18% | -5.44% | -30.87% | -47.29% | -37.28% | |
interest income | 240,000 | 194,000 | 179,000 | 222,000 | 270,000 | 228,000 | 681,000 | 592,000 | 584,000 | 631,000 | 581,000 | 487,000 | 374,000 | 263,000 | 121,000 | 22,000 | 1,000 | -11,000 | -10,000 | -12,000 | -13,000 | -17,000 | 13,000 | 2,000 | 12,000 | ||||||||||||||||||||||||||||||||||
other income | -12,000 | 10,000 | 1,051,000 | -2,750 | -25,000 | 40,000 | -10,000 | -2,000 | 10,000 | -6,000 | -4,000 | -18,000 | -5,000 | 24,000 | -38,000 | 10,000 | 35,000 | 23,000 | -23,000 | -39,000 | -6,000 | -94,000 | -17,000 | -9,000 | 5,000 | 10,000 | 17,000 | -11,000 | 29,000 | 9,000 | 39,000 | -33,000 | -7,000 | -59,000 | -2,000 | 43,000 | 1,750 | -24,000 | 55,000 | -24,000 | 10,000 | 110,000 | 60,000 | 31,000 | 10,000 | -9,000 | -15,000 | 64,000 | 7,000 | 58,000 | |||||||||
loss before income tax benefit | -4,001,000 | -4,444,000 | -108,000 | -1,205,500 | -2,649,000 | -929,500 | -3,008,000 | -1,027,000 | -956,000 | -195,000 | -636,750 | -1,458,000 | |||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -798,000 | -1,214,000 | -752,000 | -87,000 | -231,000 | -217,000 | -11,000 | -17,000 | -18,000 | -14,000 | -10,000 | -24,000 | -34,000 | -23,000 | -34,000 | -4,000 | 215,000 | -10,000 | -14,000 | -6,000 | -6,000 | -6,000 | 2,000 | -19,000 | -4,000 | -8,000 | 91,000 | -15,000 | 5,000 | 11,000 | -2,000 | -30,000 | -4,000 | 1,000 | 33,000 | -21,000 | -23,000 | 2,000 | -66,000 | -19,000 | 49,000 | 10,000 | -22,000 | -2,000 | 29,000 | -12,000 | -16,000 | -2,000 | 32,000 | 18,000 | -8,000 | ||||||||
net income | -3,203,000 | -3,230,000 | -2,084,000 | -2,899,000 | -643,000 | -1,028,000 | 660,000 | 23,864,000 | -1,471,000 | 6,089,000 | 4,674,000 | 6,111,000 | 4,132,000 | 3,725,000 | 589,000 | 5,794,000 | 2,243,000 | 717,000 | 696,000 | 567,000 | -735,000 | -1,966,000 | 107,000 | -2,885,000 | 245,000 | 251,000 | -413,000 | 110,000 | -3,201,000 | -629,000 | -1,515,000 | 191,000 | 267,000 | 60,000 | 10,000 | -795,000 | -2,651,000 | -1,452,000 | -755,000 | -3,056,000 | -2,975,000 | -1,048,000 | 294,000 | -1,900,000 | -1,726,000 | -2,114,000 | -907,000 | 239,000 | 212,000 | 137,000 | -166,000 | -854,000 | -1,458,000 | -811,000 | -296,000 | -779,000 | -1,361,000 | -1,373,000 | |
yoy | 398.13% | 214.20% | -415.76% | -112.15% | -56.29% | -116.88% | -85.88% | 290.51% | -135.60% | 63.46% | 693.55% | 5.47% | 84.22% | 419.53% | -15.37% | 921.87% | -405.17% | -136.47% | 550.47% | -119.65% | -400.00% | -883.27% | -125.91% | -2722.73% | -107.65% | -139.90% | -72.74% | -42.41% | -1298.88% | -1148.33% | -15250.00% | -124.03% | -110.07% | -104.13% | -101.32% | -13.25% | -51.19% | -27.96% | 60.84% | 72.36% | -50.43% | -132.41% | -894.98% | -914.15% | -1643.07% | 446.39% | -127.99% | -114.54% | -116.89% | -43.92% | 9.63% | 7.13% | -40.93% | ||||||
qoq | -0.84% | 54.99% | -28.11% | 350.86% | -37.45% | -255.76% | -97.23% | -1722.30% | -124.16% | 30.27% | -23.51% | 47.89% | 10.93% | 532.43% | -89.83% | 158.31% | 212.83% | 3.02% | 22.75% | -177.14% | -62.61% | -1937.38% | -103.71% | -1277.55% | -2.39% | -160.77% | -475.45% | -103.44% | 408.90% | -58.48% | -893.19% | -28.46% | 345.00% | 500.00% | -101.26% | -70.01% | 82.58% | 92.32% | 2.72% | 183.87% | -456.46% | -115.47% | 10.08% | -18.35% | 133.08% | -479.50% | 12.74% | 54.74% | -182.53% | -80.56% | -41.43% | 79.78% | 173.99% | -62.00% | -42.76% | -0.87% | |||
net income margin % | -31.06% | -32.68% | -19.00% | -20.58% | -3.51% | -7.64% | 5.03% | 143.76% | -19.45% | 28.41% | 22.66% | 27.44% | 24.01% | 25.14% | 5.52% | 28.56% | 14.68% | 7.46% | 12.33% | 7.42% | -13.95% | -116.82% | 5.32% | -76.46% | 4.01% | 3.65% | -7.46% | 1.52% | -101.20% | -10.64% | -31.96% | 2.63% | 3.61% | 0.76% | 0.14% | -11.90% | -98.88% | -34.44% | -14.20% | -194.53% | -177.40% | -22.68% | 4.43% | -104.51% | -85.15% | -80.84% | -25.49% | 4.45% | 3.78% | 2.77% | -4.42% | -25.83% | -43.65% | -16.05% | -6.13% | -28.73% | -47.67% | -35.57% | |
net income per share | -0.09 | -0.1 | -0.14 | -0.18 | -0.08 | 0.02 | 0.02 | 0.01 | -0.02 | -0.07 | -0.16 | -0.09 | -0.03 | -0.073 | -0.15 | -0.15 | |||||||||||||||||||||||||||||||||||||||||||
basic | -0.1 | -0.11 | -0.07 | -0.1 | -0.02 | -0.03 | 0.02 | 0.83 | -0.05 | 0.21 | 0.16 | 0.078 | 0.15 | 0.14 | 0.02 | 0.035 | 0.08 | 0.03 | 0.02 | -0.03 | -0.08 | 0.01 | 0.01 | 0.01 | -0.14 | -0.03 | -0.07 | 0.01 | -0.06 | ||||||||||||||||||||||||||||||
diluted | -0.1 | -0.11 | -0.07 | -0.1 | -0.02 | -0.03 | 0.02 | 0.81 | -0.05 | 0.2 | 0.16 | 0.073 | 0.14 | 0.13 | 0.02 | 0.033 | 0.08 | 0.03 | 0.02 | -0.03 | -0.08 | 0.01 | 0.01 | 0.01 | -0.14 | -0.03 | -0.07 | 0.01 | 0.01 | -0.06 | |||||||||||||||||||||||||||||
shares used in per share calculations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 30,695 | 30,177 | 29,923 | 81 | 29,733 | 29,659 | 29,107 | 45 | 28,866 | 28,801 | 28,649 | 6,892.75 | 27,893 | 27,579 | 27,242 | 6,421 | 26,871 | 26,205 | 23,999 | 67 | 23,525 | 23,396 | 23,248 | 59 | 22,937 | 22,823 | 73 | 22,459 | 22,294 | 22,190 | 101 | 21,832 | 21,645 | 21,417 | 13,317 | 12,963 | 116 | 12,677 | 11,724 | 2,701.75 | 10,982 | 10,806 | 273 | 9,363 | 9,300 | 9,166 | 27 | 9,055 | 8,980 | ||||||||||
diluted | 30,695 | 30,177 | 29,923 | 81 | 29,733 | 29,659 | 29,632 | -53 | 28,866 | 29,769 | 29,632 | 7,270 | 29,373 | 29,080 | 28,788 | 6,877.5 | 28,854 | 28,342 | 25,356 | 67 | 23,525 | 23,396 | 23,455 | -58 | 23,130 | 22,912 | 73 | 22,459 | 22,294 | 22,190 | -56 | 22,641 | 22,883 | 22,991 | 13,317 | 13,814 | 116 | 12,677 | 11,724 | 2,895.75 | 12,277 | 11,839 | 273 | 9,363 | 9,300 | 9,166 | 27 | 9,055 | 8,980 | ||||||||||
income before income taxes expense | -2,836,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenue: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
product | 10,205,000 | 16,681,000 | 11,985,000 | 12,154,000 | 15,805,000 | 6,730,000 | 19,837,000 | 19,357,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
services | 1,014,750 | 1,626,000 | 1,468,000 | 965,000 | 795,000 | 833,000 | 1,594,000 | 1,267,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenue: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income tax expense | -2,986,000 | -874,000 | -1,245,000 | 2,123,750 | 4,149,000 | 3,743,000 | 603,000 | 257,000 | -610,000 | 75,000 | -751,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
other expense | -26,000 | -60,000 | -3,000 | -21,250 | -21,000 | -30,000 | -34,000 | -19,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
income before provision for income taxes | 814,000 | 2,333,750 | -1,464,000 | 6,109,000 | 4,690,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for income taxes | 154,000 | 10,750 | 7,000 | 20,000 | 16,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain from forgiveness of ppp loan | 1,698,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain from dissolution of aehr test systems japan | 2,186,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income tax benefit | 5,804,000 | 2,267,000 | 751,000 | 719,000 | 567,000 | -701,000 | -1,962,000 | 27,250 | 259,000 | 116,000 | -3,203,000 | -1,511,000 | 199,000 | 176,000 | 5,000 | 317,000 | -1,177,750 | -1,660,000 | -2,095,000 | 229,000 | 234,000 | 139,000 | -294,000 | ||||||||||||||||||||||||||||||||||||
interest expense | -1,000 | -9,000 | -24,000 | -76,000 | -74,000 | -78,000 | -89,000 | -98,000 | -105,000 | -107,000 | -141,000 | -178,000 | -181,000 | -178,000 | -168,000 | -165,000 | -137,000 | -135,000 | -101,000 | -7,000 | -8,000 | -14,000 | -5,000 | -7,000 | -10,000 | -4,000 | -6,000 | -18,000 | -13,000 | -12,000 | |||||||||||||||||||||||||||||
net income per share | -0.09 | -0.1 | -0.14 | -0.18 | -0.08 | 0.02 | 0.02 | 0.01 | -0.02 | -0.07 | -0.16 | -0.09 | -0.03 | -0.073 | -0.15 | -0.15 | |||||||||||||||||||||||||||||||||||||||||||
basic and diluted | 0.03 | -0.02 | -0.08 | -0.16 | -0.073 | -0.23 | -0.08 | 0.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to the noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to aehr test systems common shareholders | 567,000 | -735,000 | 107,000 | -2,885,000 | 245,000 | 251,000 | 110,000 | -3,201,000 | -629,000 | -1,515,000 | 191,000 | 267,000 | 60,000 | -755,000 | 294,000 | -1,900,000 | -1,726,000 | 239,000 | 212,000 | -296,000 | |||||||||||||||||||||||||||||||||||||||
restructuring | 118,000 | 607,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss before income tax expense | -407,000 | -1,422,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to aehr test systems common shareholders | -413,000 | -1,214,500 | -2,651,000 | -1,452,000 | -932,250 | -2,975,000 | -1,048,000 | -907,000 | -166,000 | -854,000 | -1,458,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
shares used in per share calculations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | 22,708 | 3,852.75 | 16,672 | 3,264.5 | 13,164 | 13,048 | 11,391 | 10,635 | |||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to aehr test systems common shareholders | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.09 | -0.1 | -0.14 | -0.18 | -0.08 | 0.02 | 0.02 | 0.01 | -0.02 | -0.07 | -0.16 | -0.09 | -0.03 | -0.073 | -0.15 | -0.15 | |||||||||||||||||||||||||||||||||||||||||||
shares used in per share calculations: basic and diluted | 16,029 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to the noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to aehr test systems common shareolders | -2,114,000 | 137,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of long-term investment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss before income tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit | -795,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
to the noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to aehr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
test systems common shareholders | -811,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on bankruptcy claim | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expense | -656,750 | -1,343,000 | -1,381,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-02-27 | 2025-11-28 | 2025-08-29 | 2025-05-30 | 2025-02-28 | 2024-11-29 | 2024-08-30 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | 2019-11-30 | 2019-08-31 | 2019-05-31 | 2019-02-28 | 2018-11-30 | 2018-08-31 | 2018-05-31 | 2018-02-28 | 2017-11-30 | 2017-08-31 | 2017-05-31 | 2017-02-28 | 2016-11-30 | 2016-08-31 | 2016-05-31 | 2016-05-30 | 2016-02-29 | 2015-11-30 | 2015-08-31 | 2015-05-31 | 2015-02-28 | 2014-11-30 | 2014-08-31 | 2014-05-31 | 2014-02-28 | 2013-11-30 | 2013-08-31 | 2013-05-31 | 2013-02-28 | 2012-11-30 | 2012-08-31 | 2012-05-31 | 2012-02-29 | 2011-11-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 36,911,000 | 30,835,000 | 22,708,000 | 24,529,000 | 29,411,000 | 32,217,000 | 37,830,000 | 49,159,000 | 47,581,000 | 50,514,000 | 50,955,000 | 30,054,000 | 17,188,000 | 18,874,000 | 36,147,000 | 31,484,000 | 32,020,000 | 35,031,000 | 6,530,000 | 4,582,000 | 4,738,000 | 3,449,000 | 6,313,000 | 5,433,000 | 5,058,000 | 5,302,000 | 5,266,000 | 5,428,000 | 12,300,000 | 14,002,000 | 15,864,000 | 16,848,000 | 9,077,000 | 9,959,000 | 13,993,000 | 17,803,000 | 2,039,000 | 5,154,000 | 2,342,000 | 939,000 | 939,000 | 2,472,000 | 1,955,000 | 3,653,000 | 5,527,000 | 2,274,000 | 3,596,000 | 2,075,000 | 1,809,000 | 1,846,000 | 2,494,000 | 2,435,000 | 2,324,000 | 1,381,000 | 1,192,000 | 1,901,000 | 2,073,000 | 2,975,000 | 3,126,000 |
accounts receivable | 11,808,000 | 10,282,000 | 13,055,000 | 14,191,000 | 11,991,000 | 7,333,000 | 8,561,000 | 9,796,000 | 5,468,000 | 4,573,000 | 13,161,000 | 16,594,000 | 11,389,000 | 10,156,000 | 5,116,000 | 12,859,000 | 8,543,000 | 7,391,000 | 4,264,000 | 5,202,000 | 2,721,000 | 1,429,000 | 1,116,000 | 3,717,000 | 3,511,000 | 5,231,000 | 3,287,000 | 4,859,000 | 1,944,000 | 3,868,000 | 2,272,000 | 2,856,000 | 4,673,000 | 3,490,000 | 5,301,000 | 4,010,000 | 1,596,000 | 1,429,000 | 1,774,000 | 522,000 | 522,000 | 1,947,000 | 2,503,000 | 2,628,000 | 1,383,000 | 597,000 | 1,352,000 | 2,098,000 | 3,390,000 | 3,378,000 | 2,735,000 | 2,860,000 | 2,632,000 | 1,570,000 | 2,588,000 | ||||
inventories | 41,162,000 | 42,723,000 | 41,842,000 | 41,997,000 | 42,329,000 | 43,776,000 | 42,973,000 | 37,470,000 | 38,085,000 | 33,817,000 | 31,557,000 | 23,908,000 | 21,619,000 | 17,972,000 | 17,233,000 | 15,051,000 | 14,152,000 | 13,033,000 | 10,146,000 | 8,849,000 | 8,339,000 | 9,057,000 | 8,102,000 | 7,989,000 | 9,330,000 | 9,800,000 | 9,217,000 | 9,061,000 | 9,189,000 | 9,983,000 | 9,585,000 | 9,049,000 | 9,368,000 | 8,225,000 | 9,020,000 | 6,604,000 | 7,207,000 | 6,069,000 | 6,031,000 | 7,033,000 | 7,033,000 | 7,378,000 | 7,419,000 | 7,258,000 | 7,123,000 | 6,854,000 | 6,035,000 | 6,304,000 | 6,148,000 | 5,931,000 | 5,650,000 | 5,369,000 | 5,369,000 | 5,722,000 | 6,444,000 | 6,710,000 | 6,070,000 | 5,650,000 | 5,579,000 |
prepaid expenses and other current assets | 6,019,000 | 4,349,000 | 6,447,000 | 8,061,000 | 7,968,000 | 5,195,000 | 3,555,000 | 1,423,000 | 1,215,000 | 2,861,000 | 540,000 | 621,000 | 808,000 | 823,000 | 833,000 | 559,000 | 622,000 | 759,000 | 571,000 | 433,000 | 439,000 | 586,000 | 534,000 | 523,000 | 787,000 | 688,000 | 727,000 | 1,339,000 | 2,098,000 | 2,050,000 | 354,000 | 390,000 | 305,000 | ||||||||||||||||||||||||||
total current assets | 95,900,000 | 88,189,000 | 84,052,000 | 88,778,000 | 91,699,000 | 88,521,000 | 92,919,000 | 97,848,000 | 92,349,000 | 91,765,000 | 96,213,000 | 89,030,000 | 76,581,000 | 65,535,000 | 59,329,000 | 60,007,000 | 55,274,000 | 56,077,000 | 21,699,000 | 19,184,000 | 16,369,000 | 14,368,000 | 15,970,000 | 17,651,000 | 18,485,000 | 20,867,000 | 18,293,000 | 20,034,000 | 24,220,000 | 28,541,000 | 28,448,000 | 29,456,000 | 30,443,000 | 29,741,000 | 30,364,000 | 29,378,000 | 11,196,000 | 13,042,000 | 10,452,000 | 8,748,000 | 8,748,000 | 12,094,000 | 12,279,000 | 14,004,000 | 14,295,000 | 10,153,000 | 11,342,000 | 10,828,000 | 11,673,000 | 11,554,000 | 11,299,000 | 11,120,000 | 10,522,000 | 8,878,000 | 10,925,000 | 11,495,000 | 10,928,000 | 9,697,000 | 11,024,000 |
property and equipment | 9,277,000 | 8,987,000 | 9,001,000 | 8,969,000 | 7,028,000 | 4,306,000 | 3,503,000 | 3,253,000 | 3,150,000 | 3,185,000 | 3,083,000 | 2,759,000 | 1,281,000 | 1,263,000 | 1,322,000 | 1,203,000 | 776,000 | 661,000 | 676,000 | 677,000 | 617,000 | 683,000 | 622,000 | 663,000 | 783,000 | 860,000 | 1,000,000 | 1,045,000 | 975,000 | 1,074,000 | 1,174,000 | 1,203,000 | 1,205,000 | 1,166,000 | 1,140,000 | 1,419,000 | 861,000 | 793,000 | 789,000 | 1,204,000 | 1,204,000 | 1,251,000 | 576,000 | 465,000 | 478,000 | 502,000 | 538,000 | 492,000 | 474,000 | 311,000 | 249,000 | 246,000 | 301,000 | 378,000 | 358,000 | 439,000 | 510,000 | 587,000 | 707,000 |
goodwill | 10,719,000 | 10,719,000 | 10,719,000 | 10,719,000 | 10,742,000 | 10,742,000 | 10,353,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets | 9,847,000 | 10,143,000 | 10,439,000 | 10,781,000 | 11,147,000 | 11,512,000 | 11,854,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax assets | 21,883,000 | 21,076,000 | 19,875,000 | 19,114,000 | 18,789,000 | 18,585,000 | 18,351,000 | 20,773,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease right-of-use assets | 9,089,000 | 9,272,000 | 9,422,000 | 9,601,000 | 5,749,000 | 6,038,000 | 6,325,000 | 5,734,000 | 5,863,000 | 5,987,000 | 5,951,000 | 6,123,000 | 6,293,000 | 561,000 | 740,000 | 917,000 | 1,091,000 | 1,265,000 | 1,437,000 | 1,606,000 | 1,763,000 | 1,918,000 | 1,952,000 | 2,107,000 | 2,260,000 | 2,387,000 | 2,533,000 | ||||||||||||||||||||||||||||||||
other non-current assets | 331,000 | 348,000 | 584,000 | 546,000 | 453,000 | 2,576,000 | 2,557,000 | 304,000 | 234,000 | 238,000 | 222,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total assets | 157,046,000 | 148,734,000 | 144,092,000 | 148,508,000 | 145,607,000 | 142,280,000 | 145,862,000 | 127,912,000 | 101,596,000 | 101,175,000 | 105,469,000 | 98,143,000 | 84,396,000 | 67,543,000 | 61,578,000 | 62,328,000 | 57,355,000 | 58,185,000 | 24,001,000 | 21,665,000 | 18,891,000 | 17,111,000 | 18,691,000 | 20,574,000 | 21,688,000 | 24,300,000 | 22,025,000 | 21,307,000 | 25,451,000 | 29,901,000 | 29,888,000 | 30,955,000 | 31,972,000 | 31,001,000 | 31,599,000 | 30,892,000 | 12,153,000 | 13,930,000 | 11,336,000 | 10,046,000 | 10,046,000 | 13,439,000 | 12,948,000 | 14,563,000 | 14,868,000 | 10,749,000 | 11,974,000 | 11,415,000 | 12,225,000 | 11,943,000 | 11,626,000 | 11,444,000 | 10,975,000 | 9,415,000 | 11,452,000 | 12,108,000 | 11,613,000 | 10,456,000 | 11,908,000 |
liabilities and shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 2,103,000 | 3,548,000 | 3,380,000 | 6,728,000 | 6,961,000 | 4,854,000 | 5,571,000 | 5,332,000 | 4,979,000 | 4,183,000 | 8,328,000 | 9,206,000 | 4,988,000 | 3,949,000 | 3,387,000 | 4,195,000 | 3,307,000 | 3,386,000 | 2,753,000 | 2,893,000 | 1,086,000 | 1,155,000 | 809,000 | 945,000 | 925,000 | 2,320,000 | 1,742,000 | 1,933,000 | 557,000 | 1,953,000 | 1,317,000 | 1,762,000 | 2,638,000 | 1,789,000 | 3,473,000 | 2,808,000 | 1,821,000 | 1,770,000 | 1,906,000 | 1,413,000 | 1,413,000 | 1,883,000 | 1,390,000 | 1,848,000 | 724,000 | 1,631,000 | 1,790,000 | 1,586,000 | 1,892,000 | 1,892,000 | 1,403,000 | 1,188,000 | 1,517,000 | 1,461,000 | 2,001,000 | 1,507,000 | 960,000 | 1,494,000 | |
accrued expenses and other current liabilities | 4,176,000 | 3,729,000 | 6,509,000 | 6,020,000 | 7,086,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease liabilities, short-term | 606,000 | 585,000 | 905,000 | 909,000 | 1,173,000 | 858,000 | 827,000 | 465,000 | 428,000 | 397,000 | 275,000 | 137,000 | 68,000 | 551,000 | 741,000 | 794,000 | 778,000 | 763,000 | 750,000 | 737,000 | 722,000 | 705,000 | 671,000 | 658,000 | 644,000 | 619,000 | 606,000 | ||||||||||||||||||||||||||||||||
deferred revenue, short-term | 1,857,000 | 443,000 | 1,119,000 | 1,981,000 | 844,000 | 613,000 | 3,541,000 | 1,345,000 | 486,000 | 147,000 | 6,114,000 | 238,000 | |||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities | 8,742,000 | 8,305,000 | 11,913,000 | 15,638,000 | 16,064,000 | 11,717,000 | 15,420,000 | 10,508,000 | 9,180,000 | 7,959,000 | 19,253,000 | 16,308,000 | 9,388,000 | 10,746,000 | 9,899,000 | 11,014,000 | 12,817,000 | 16,545,000 | 8,760,000 | 9,061,000 | 6,911,000 | 4,483,000 | 4,173,000 | 3,865,000 | 3,327,000 | 6,344,000 | 4,540,000 | 5,512,000 | 10,019,000 | 11,618,000 | 11,264,000 | 11,148,000 | 6,591,000 | 6,538,000 | 8,079,000 | 7,884,000 | 4,730,000 | 4,191,000 | 6,002,000 | 4,680,000 | 4,680,000 | 7,367,000 | 4,181,000 | 5,224,000 | 6,519,000 | 4,833,000 | 4,472,000 | 4,782,000 | 5,117,000 | 5,463,000 | 5,651,000 | 6,200,000 | 5,701,000 | 4,524,000 | 5,351,000 | 5,426,000 | 4,855,000 | 3,082,000 | 3,318,000 |
operating lease liabilities, long-term | 9,419,000 | 9,578,000 | 9,710,000 | 9,921,000 | 5,267,000 | 5,574,000 | 5,878,000 | 5,732,000 | 5,878,000 | 6,016,000 | 5,997,000 | 6,163,000 | 6,324,000 | 65,000 | 73,000 | 212,000 | 415,000 | 616,000 | 813,000 | 1,007,000 | 1,185,000 | 1,361,000 | 1,432,000 | 1,605,000 | 1,772,000 | 1,924,000 | 2,086,000 | ||||||||||||||||||||||||||||||||
deferred revenue, long-term | 53,000 | 35,000 | 35,000 | 36,000 | 26,000 | 52,000 | 60,000 | 41,000 | 4,000 | 33,000 | 31,000 | 8,000 | 25,000 | 47,000 | 69,000 | 90,000 | 116,000 | 150,000 | 99,000 | 80,000 | 9,000 | 19,000 | 22,000 | 34,000 | 64,000 | 113,000 | 189,000 | 240,000 | 252,000 | 359,000 | 459,000 | 497,000 | 251,000 | 97,000 | 104,000 | 32,000 | 47,000 | 63,000 | 127,000 | 127,000 | 127,000 | 127,000 | 127,000 | 8,000 | 20,000 | 36,000 | 68,000 | 122,000 | |||||||||||
other long-term liabilities | 40,000 | 40,000 | 40,000 | 42,000 | 40,000 | 1,756,000 | 2,021,000 | 38,000 | 41,000 | 42,000 | 41,000 | 41,000 | 42,000 | 41,000 | 44,000 | 45,000 | 46,000 | 49,000 | 43,000 | ||||||||||||||||||||||||||||||||||||||||
total liabilities | 18,254,000 | 17,958,000 | 21,698,000 | 25,637,000 | 21,397,000 | 19,099,000 | 23,379,000 | 16,319,000 | 15,099,000 | 14,021,000 | 25,324,000 | 22,543,000 | 15,762,000 | 10,876,000 | 10,060,000 | 11,339,000 | 13,367,000 | 17,323,000 | 9,769,000 | 10,216,000 | 8,406,000 | 6,319,000 | 6,370,000 | 6,518,000 | 5,133,000 | 8,332,000 | 6,739,000 | 5,854,000 | 10,410,000 | 12,017,000 | 11,768,000 | 11,670,000 | 13,198,000 | 12,899,000 | 14,286,000 | 14,098,000 | 10,857,000 | 10,289,000 | 12,071,000 | 10,769,000 | 10,769,000 | 11,411,000 | 8,181,000 | 9,179,000 | 10,318,000 | 4,841,000 | 4,480,000 | 4,790,000 | 5,196,000 | 5,580,000 | 5,803,000 | 6,392,000 | 5,981,000 | 4,883,000 | 5,607,000 | 5,699,000 | 5,159,000 | 3,406,000 | 3,655,000 |
commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.01 par value: authorized: 10,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock | 299,000 | 285,000 | 283,000 | 277,000 | 274,000 | 271,000 | 269,000 | 268,000 | 245,000 | 237,000 | 236,000 | 235,000 | 233,000 | 231,000 | 230,000 | 227,000 | 226,000 | 224,000 | 222,000 | 221,000 | 215,000 | 213,000 | 130,000 | ||||||||||||||||||||||||||||||||||||
issued and outstanding: 30,954 shares and 29,877 shares at february 27, 2026 and may 30, 2025, respectively | 310,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital | 170,143,000 | 158,954,000 | 147,333,000 | 145,758,000 | 127,776,000 | 126,930,000 | 119,094,000 | 117,668,000 | 116,507,000 | 115,602,000 | 89,668,000 | 87,553,000 | 87,174,000 | 86,786,000 | 86,356,000 | 85,898,000 | 85,530,000 | 85,194,000 | 84,760,000 | 84,499,000 | 84,176,000 | 83,830,000 | 83,405,000 | 83,041,000 | 82,671,000 | 82,304,000 | 81,576,000 | 81,128,000 | 64,939,000 | 64,636,000 | 58,784,000 | 58,052,000 | 58,052,000 | 57,770,000 | 57,557,000 | 57,068,000 | 56,547,000 | 55,976,000 | 55,725,000 | 52,678,000 | 52,142,000 | 51,703,000 | 51,390,000 | 50,781,000 | 50,580,000 | 49,251,000 | 49,093,000 | 48,857,000 | 48,622,000 | 48,378,000 | 48,196,000 | ||||||||
accumulated other comprehensive loss | -84,000 | -110,000 | -95,000 | -126,000 | -181,000 | -191,000 | -134,000 | -158,000 | -144,000 | -134,000 | -141,000 | -155,000 | -162,000 | -155,000 | -150,000 | -131,000 | |||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -31,577,000 | -28,374,000 | -25,144,000 | -23,060,000 | -20,161,000 | -19,518,000 | -18,490,000 | -19,150,000 | -43,014,000 | -41,543,000 | -47,632,000 | -52,306,000 | -58,417,000 | -62,549,000 | -66,274,000 | -66,863,000 | -72,657,000 | -74,900,000 | -75,617,000 | -76,313,000 | -76,880,000 | -76,167,000 | -74,201,000 | -74,286,000 | -71,401,000 | -71,646,000 | -71,897,000 | -71,484,000 | -71,594,000 | -68,393,000 | -67,764,000 | -66,249,000 | -66,440,000 | -66,707,000 | -66,767,000 | -66,777,000 | -65,982,000 | -63,331,000 | -61,879,000 | -61,124,000 | -61,124,000 | -58,068,000 | -55,093,000 | -54,045,000 | -54,339,000 | -52,439,000 | -50,713,000 | -48,599,000 | -47,692,000 | -47,931,000 | -48,143,000 | -48,280,000 | -48,114,000 | -47,261,000 | -45,802,000 | -44,991,000 | -44,717,000 | -43,938,000 | -42,577,000 |
total shareholders' equity | 138,792,000 | 130,776,000 | 122,394,000 | 122,871,000 | 124,210,000 | 123,181,000 | 122,483,000 | 111,593,000 | 86,497,000 | 87,154,000 | 80,145,000 | 75,600,000 | 68,634,000 | 51,518,000 | 50,989,000 | 43,988,000 | 14,232,000 | 11,449,000 | 10,485,000 | 10,792,000 | 12,321,000 | 14,056,000 | 16,555,000 | 15,968,000 | 15,286,000 | 15,453,000 | 15,041,000 | 17,884,000 | 18,120,000 | 19,285,000 | 18,774,000 | 18,102,000 | 17,313,000 | 16,794,000 | 1,296,000 | 3,641,000 | -723,000 | -723,000 | 2,028,000 | 4,767,000 | 5,384,000 | 4,550,000 | 5,908,000 | 7,494,000 | 6,625,000 | 7,029,000 | 6,363,000 | 5,823,000 | 5,052,000 | 4,994,000 | 4,532,000 | 5,845,000 | 6,409,000 | 6,454,000 | 7,050,000 | 8,253,000 | |||
total liabilities and shareholders’ equity | 157,046,000 | 148,734,000 | 145,607,000 | 145,862,000 | 127,912,000 | 101,596,000 | 101,175,000 | 105,469,000 | 67,543,000 | 58,185,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 30,624 shares and 29,877 shares at november 28, 2025 and may 30, 2025, respectively | 306,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 29,973 shares and 29,877 shares at august 29, 2025 and may 30, 2025, respectively | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders equity | 144,092,000 | 148,508,000 | 142,280,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.01 par value: authorized: 10,000 shares; issued and outstanding: none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 29,770 shares and 28,995 shares at february 28, 2025 and may 31, 2024, respectively | 298,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additional paid-in-capital | 144,254,000 | 142,593,000 | 140,812,000 | 130,612,000 | 129,366,000 | 128,543,000 | 127,630,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses | 5,392,000 | 5,481,000 | 3,366,000 | 3,287,000 | 3,232,000 | 4,536,000 | 4,143,000 | 3,489,000 | 2,566,000 | 2,479,000 | 3,610,000 | 2,535,000 | 2,254,000 | 1,978,000 | 2,163,000 | 1,624,000 | 1,344,000 | 1,373,000 | 1,439,000 | 1,373,000 | 1,596,000 | 1,577,000 | 2,034,000 | 2,085,000 | 1,487,000 | 1,498,000 | 1,646,000 | 1,643,000 | 1,607,000 | 1,572,000 | 1,609,000 | 1,897,000 | 1,366,000 | 1,372,000 | 1,553,000 | 1,553,000 | 1,458,000 | 1,496,000 | 1,557,000 | 1,045,000 | 1,375,000 | 1,248,000 | 1,435,000 | 1,390,000 | 1,447,000 | 1,245,000 | 1,437,000 | 1,440,000 | 1,554,000 | 1,611,000 | 1,580,000 | 1,385,000 | 1,221,000 | 1,553,000 | |||||
issued and outstanding: 29,709 shares and 28,995 shares at november 29, 2024 and may 31, 2024, respectively | 297,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 29,584 shares and 28,995 shares at at august 30, 2024 and may 31, 2024, respectively | 295,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term investments | 17,853,000 | 25,577,000 | 17,710,000 | 5,986,000 | 5,969,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 28,995 shares and 28,539 shares at may 31, 2024 and 2023, respectively | 289,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 28,906 shares and 28,539 shares at february 29, 2024 and may 31, 2023, respectively | 289,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 28,826 shares and 28,539 shares at november 30, 2023 and may 31, 2023, respectively | 288,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 28,763 shares and 28,539 shares at august 31, 2023 and may 31, 2023, respectively | 288,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 231,000 | 241,000 | 184,000 | 187,000 | 201,000 | 214,000 | 182,000 | 189,000 | 198,000 | 142,000 | 142,000 | 147,000 | 153,000 | 160,000 | 186,000 | 199,000 | 228,000 | 256,000 | 286,000 | 266,000 | 296,000 | 324,000 | 94,000 | 95,000 | 95,000 | 96,000 | 95,000 | 95,000 | 94,000 | 94,000 | 94,000 | 93,000 | 94,000 | 95,000 | 94,000 | 94,000 | 95,000 | 78,000 | 78,000 | 78,000 | 78,000 | 152,000 | 159,000 | 169,000 | 174,000 | 175,000 | 172,000 | 177,000 | |||||||||||
liabilities and shareholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
customer deposits and deferred revenue, short-term | 2,822,000 | 843,000 | 3,680,000 | 3,292,000 | 2,415,000 | 6,197,000 | 10,142,000 | 3,279,000 | 189,000 | 587,000 | 66,000 | 387,000 | 170,000 | 385,000 | 1,809,000 | 615,000 | 1,545,000 | 1,267,000 | 2,068,000 | 2,339,000 | 1,630,000 | 2,310,000 | 3,142,000 | 3,034,000 | 1,012,000 | 1,055,000 | 2,724,000 | 2,026,000 | 1,295,000 | 1,819,000 | 792,000 | 761,000 | 1,058,000 | 1,345,000 | 2,038,000 | 2,413,000 | 1,972,000 | ||||||||||||||||||||||
shareholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders' equity | 98,143,000 | 84,396,000 | 61,578,000 | 62,328,000 | 57,355,000 | 24,001,000 | 21,665,000 | 18,891,000 | 17,111,000 | 18,691,000 | 20,574,000 | 21,688,000 | 24,300,000 | 22,025,000 | 21,307,000 | 25,451,000 | 29,901,000 | 29,888,000 | 30,955,000 | 31,972,000 | 31,001,000 | 31,599,000 | 30,892,000 | 12,153,000 | 13,930,000 | 10,046,000 | 10,046,000 | 13,439,000 | 12,948,000 | 14,563,000 | 14,868,000 | 10,749,000 | 11,974,000 | 11,415,000 | 12,225,000 | 11,943,000 | 11,626,000 | 11,444,000 | 10,975,000 | 9,415,000 | 11,452,000 | 12,108,000 | 11,613,000 | 10,456,000 | 11,908,000 | ||||||||||||||
other liabilities | 40,000 | 46,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders’ equity | 56,667,000 | 40,862,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aehr test systems shareholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other | 613,000 | 551,000 | 512,000 | 686,000 | 703,000 | 961,000 | 254,000 | 254,000 | 297,000 | 402,000 | 465,000 | 262,000 | 428,000 | 359,000 | 351,000 | 326,000 | 399,000 | 420,000 | 456,000 | 197,000 | 205,000 | 390,000 | 326,000 | 197,000 | 247,000 | 218,000 | |||||||||||||||||||||||||||||||||
line of credit | 1,400,000 | 1,400,000 | 2,000,000 | 115,000 | 642,000 | 1,000,000 | 777,000 | 406,000 | 476,000 | 947,000 | 1,101,000 | 1,215,000 | 1,685,000 | 1,452,000 | 1,408,000 | 716,000 | |||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 1,679,000 | 1,492,000 | 1,213,000 | 933,000 | 653,000 | 6,110,000 | 6,110,000 | 6,110,000 | 6,110,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
additional paid-in capital common stock | 117,686,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -105,000 | -108,000 | -64,000 | -28,000 | -45,000 | -62,000 | -67,000 | 2,234,000 | 2,216,000 | 2,211,000 | 2,216,000 | 2,230,000 | 2,252,000 | 2,241,000 | 2,276,000 | 2,292,000 | 2,344,000 | 2,306,000 | 2,308,000 | 2,249,000 | 2,190,000 | 2,188,000 | 2,245,000 | 2,237,000 | 2,237,000 | 2,213,000 | 2,189,000 | 2,249,000 | 2,231,000 | 2,262,000 | 2,373,000 | 2,451,000 | 2,488,000 | 2,502,000 | 2,488,000 | 2,465,000 | 2,442,000 | 2,469,000 | 2,482,000 | 2,473,000 | 2,458,000 | 2,519,000 | 2,543,000 | ||||||||||||||||
aehr test systems shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term debt | 187,000 | 466,000 | 746,000 | 1,026,000 | 6,110,000 | 6,110,000 | 6,095,000 | 6,051,000 | 6,006,000 | 3,917,000 | 3,873,000 | 3,828,000 | 3,791,000 | ||||||||||||||||||||||||||||||||||||||||||||||
total aehr test systems shareholders' equity | 11,449,000 | 10,485,000 | 10,792,000 | 12,321,000 | 14,077,000 | 16,575,000 | 15,988,000 | 15,306,000 | 15,472,000 | 15,060,000 | 17,902,000 | 18,139,000 | 19,305,000 | 18,794,000 | 18,121,000 | 17,332,000 | 16,813,000 | 1,315,000 | 3,660,000 | -703,000 | -703,000 | 2,047,000 | 4,785,000 | 5,402,000 | 4,568,000 | 5,926,000 | 7,512,000 | 6,645,000 | 7,050,000 | 6,384,000 | 5,844,000 | 5,073,000 | 5,014,000 | 4,553,000 | 5,867,000 | 6,431,000 | |||||||||||||||||||||||
noncontrolling interest | -21,000 | -20,000 | -20,000 | -20,000 | -19,000 | -19,000 | -18,000 | -19,000 | -20,000 | -20,000 | -19,000 | -19,000 | -19,000 | -19,000 | -19,000 | -21,000 | -20,000 | -20,000 | -19,000 | -18,000 | -18,000 | -18,000 | -18,000 | -18,000 | -20,000 | -21,000 | -21,000 | -21,000 | -20,000 | -21,000 | -22,000 | -22,000 | |||||||||||||||||||||||||||
deferred rent | 153,000 | 151,000 | 147,000 | 145,000 | 63,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
aehr test systems shareholders' equity: preferred stock, 0.01 par value: authorized: 10,000 shares; issued and outstanding: none | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 22,914 shares and 22,669 shares at november 30, 2019 and may 31, 2019, respectively | 229,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 22,721 shares and 22,669 shares at august 31, 2019 and may 31, 2019, respectively | 227,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible notes | 6,110,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 21,943 shares and 21,340 shares at february 28, 2018 and may 31, 2017, respectively | 219,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 21,797 shares and 21,340 shares at november 30, 2017 and may 31, 2017, respectively | 218,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
customer deposits and deferred revenue | 3,467,000 | 1,714,000 | 1,714,000 | 4,750,000 | 1,712,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible notes, net of debt issuance costs | 6,110,000 | 5,962,000 | 5,962,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aehr test systems shareholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 16,754 shares and 13,216 shares at february 28, 2017 and may 31, 2016, respectively | 168,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 16,639 shares and 13,216 shares at november 30, 2016 and may 31, 2016, respectively | 167,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders' deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aehr test systems shareholders' deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 13,589 shares and 13,216 shares at august 31, 2016 and may 31, 2016, respectively | 136,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total aehr test systems shareholders' deficit | -714,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders' deficit | -735,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders' deficit | 11,336,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | 8,000 | 8,000 | 8,000 | 8,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.01 par value: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 10,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 13,216 shares and 12,857 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares at may 31, 2016 and 2015, respectively | 132,000 | 132,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 13,164 shares and 12,857 shares at february 29, 2016 and may 31, 2015, respectively | 132,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 13,164 shares and 12,857 shares at november 30, 2015 and may 31, 2015, respectively | 132,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred rent, net of current portion | 8,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 12,857 shares and 11,203 shares at may 31, 2015 and 2014, respectively | 129,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 12,695 shares and 11,203 shares at february 28, 2015 and may 31, 2014, respectively | 127,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized: 75,000 shares; issued and outstanding: 12,667 shares and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11,203 shares at november 30, 2014 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
may 31, 2014, respectively | 127,000 | 115,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 11,498 shares and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11,203 shares at august 31, 2014 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payable | 71,000 | 77,000 | 76,000 | 76,000 | 109,000 | 115,000 | 114,000 | 112,000 | 125,000 | 129,000 | 128,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 11,203 shares and 10,599 shares at may 31, 2014 and 2013, respectively | 112,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interest. | -21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acounts payable | 2,265,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred lease commitment | 32,000 | 56,000 | 80,000 | 122,000 | 142,000 | 161,000 | 179,000 | 195,000 | 209,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 11,018 shares and 10,599 shares at february 28, 2014 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
may 31, 2013, respectively | 110,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 10,934 shares and 10,599 shares at november 30, 2013 and may 31, 2013, respectively | 109,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 10,668 shares and 10,599 shares at august 31, 2013 and may 31, 2013, respectively | 107,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred lease commitment, net of current portion | 103,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 10,599 shares and 9,135 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares at may 31, 2013 and 2012, respectively | 106,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 9,363 shares and 9,135 shares at february 28, 2013 and may 31, 2012, respectively | 94,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
doubtful accounts of 44 and 39 at | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
november 30, 2012 and may 31, 2012, respectively | 2,899,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | 594,000 | 393,000 | 555,000 | 185,000 | 271,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 9,363 shares and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9,135 shares at november 30, 2012 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
may 31, 2012, respectively | 94,000 | 92,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
doubtful accounts of 38 and 39 at | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
august 31, 2012 and may 31, 2012, respectively | 2,558,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 9,236 shares and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9,135 shares at august 31, 2012 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 9,135 shares and 8,932 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares at may 31, 2012 and 2011, respectively | 91,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
doubtful accounts of 14 and 23 at | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
february 29, 2012 and may 31, 2011, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
respectively | 825,000 | 2,101,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issued and outstanding: 9,055 shares and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8,932 shares at february 29, 2012 and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
may 31, 2011, respectively | 91,000 | 91,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
doubtful accounts of 32 and 23 at | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
november 30, 2011 and may 31, 2011, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8,932 shares at november 30, 2011 and |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-02-27 | 2025-11-28 | 2025-08-29 | 2025-05-30 | 2025-02-28 | 2024-11-29 | 2024-08-30 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-02-28 | 2020-11-30 | 2020-08-31 | 2020-05-31 | 2020-02-29 | 2019-11-30 | 2019-08-31 | 2019-05-31 | 2019-02-28 | 2018-11-30 | 2018-08-31 | 2018-05-31 | 2018-02-28 | 2017-11-30 | 2017-08-31 | 2017-05-31 | 2017-02-28 | 2016-11-30 | 2016-08-31 | 2016-05-30 | 2016-02-29 | 2015-11-30 | 2015-08-31 | 2015-05-31 | 2015-02-28 | 2014-11-30 | 2014-08-31 | 2014-05-31 | 2014-02-28 | 2013-11-30 | 2013-08-31 | 2013-05-31 | 2013-02-28 | 2012-11-30 | 2012-08-31 | 2012-05-31 | 2012-02-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -3,203,000 | 251,000 | -413,000 | -795,000 | -2,651,000 | -2,975,000 | -2,114,000 | -907,000 | 137,000 | -166,000 | -854,000 | -1,458,000 | -779,000 | -1,361,000 | |||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | 1,384,000 | 1,841,000 | 1,671,000 | 1,421,000 | 1,796,000 | 1,075,000 | 870,000 | 774,000 | 584,000 | 638,000 | 522,000 | 592,000 | 793,000 | 710,000 | 880,000 | 718,000 | 588,000 | 303,000 | 271,000 | 299,000 | 207,000 | 205,000 | 199,000 | 200,000 | 225,000 | 224,000 | 256,000 | 174,000 | 242,000 | 364,000 | 216,000 | 208,000 | 257,000 | 215,000 | 319,000 | 230,000 | 213,000 | 254,000 | 319,000 | 304,000 | 219,000 | 277,000 | 197,000 | 204,000 | 235,000 | 247,000 | 143,000 | 174,000 | 201,000 | ||||||||
depreciation and amortization | 677,000 | 690,000 | 743,000 | 739,000 | 620,000 | 606,000 | 347,000 | 188,000 | 186,000 | 145,000 | 138,000 | 113,000 | 146,000 | 102,000 | 89,000 | 81,000 | 77,000 | 76,000 | 73,000 | 71,000 | 74,000 | 83,000 | 82,000 | 86,000 | 105,000 | 98,000 | 95,000 | 98,000 | 103,000 | 119,000 | 111,000 | 117,000 | 110,000 | 101,000 | 89,000 | 76,000 | 66,000 | 61,000 | 68,000 | 80,000 | 50,000 | 36,000 | 37,000 | 37,000 | 37,000 | 32,000 | 29,000 | 22,000 | 24,000 | 42,000 | 53,000 | 75,000 | 77,000 | 84,000 | 86,000 | 103,000 | 120,000 |
deferred income taxes | -807,000 | -1,201,000 | -761,000 | -128,000 | -203,000 | -234,000 | 144,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of operating lease right-of-use assets | 183,000 | 181,000 | 179,000 | 281,000 | 289,000 | 287,000 | 219,000 | 184,000 | 185,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -1,504,000 | 2,751,000 | 1,140,000 | -2,075,000 | -4,680,000 | 1,163,000 | 2,555,000 | -4,340,000 | -907,000 | 8,600,000 | 3,437,000 | 7,648,000 | -4,380,000 | -1,170,000 | -3,179,000 | 895,000 | -2,436,000 | -1,278,000 | -301,000 | 2,642,000 | -199,000 | 1,732,000 | -1,956,000 | 1,584,000 | -2,914,000 | 1,939,000 | -1,631,000 | 563,000 | 1,787,000 | -1,119,000 | 1,852,000 | -1,260,000 | -2,388,000 | -147,000 | 278,000 | -1,250,000 | 1,479,000 | 604,000 | 61,000 | -1,257,000 | -810,000 | 639,000 | 673,000 | 1,272,000 | -35,000 | -627,000 | 158,000 | -216,000 | -1,157,000 | 1,248,000 | -350,000 | 53,000 | -1,820,000 | 1,196,000 | |||
inventories | 857,000 | -872,000 | 218,000 | -230,000 | 1,427,000 | -758,000 | -2,880,000 | 450,000 | -4,186,000 | -2,292,000 | -7,704,000 | -2,686,000 | -3,689,000 | -771,000 | -2,323,000 | -1,225,000 | -1,237,000 | -2,888,000 | -1,324,000 | -623,000 | 718,000 | -955,000 | -112,000 | 1,321,000 | 470,000 | -471,000 | -156,000 | 9,000 | 814,000 | -399,000 | -536,000 | 319,000 | -1,143,000 | 795,000 | -2,044,000 | 233,000 | -1,138,000 | -39,000 | 1,374,000 | 345,000 | 41,000 | -160,000 | -156,000 | -302,000 | -825,000 | 275,000 | -156,000 | -194,000 | -265,000 | 327,000 | 679,000 | 336,000 | -640,000 | -420,000 | -72,000 | ||
prepaid expenses and other assets | 29,000 | 32,000 | -137,000 | -24,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | -1,362,000 | 287,000 | -2,401,000 | -853,000 | 2,019,000 | -1,252,000 | -628,000 | 341,000 | 867,000 | -4,160,000 | -939,000 | 4,222,000 | 1,032,000 | 559,000 | -769,000 | 912,000 | -68,000 | 642,000 | -130,000 | 1,799,000 | -82,000 | 333,000 | -173,000 | 9,000 | -1,422,000 | 624,000 | -235,000 | 1,342,000 | -1,434,000 | 700,000 | -398,000 | -827,000 | 737,000 | -1,656,000 | 651,000 | 960,000 | 5,000 | 8,000 | 713,000 | -504,000 | 381,000 | -426,000 | 1,113,000 | -856,000 | -119,000 | 395,000 | -270,000 | -368,000 | 364,000 | 536,000 | 175,000 | -136,000 | 325,000 | -431,000 | 485,000 | 464,000 | -377,000 |
accrued expenses | 445,000 | -988,000 | 505,000 | 137,000 | -520,000 | -283,000 | 288,000 | 82,000 | 100,000 | -1,329,000 | 355,000 | 654,000 | 919,000 | 85,000 | -1,130,000 | 1,089,000 | 271,000 | 273,000 | -169,000 | 553,000 | 276,000 | -30,000 | -67,000 | 85,000 | -236,000 | 17,000 | -455,000 | -29,000 | 606,000 | -24,000 | -151,000 | 31,000 | 26,000 | 26,000 | -21,000 | -272,000 | 526,000 | -20,000 | -181,000 | 105,000 | -5,000 | -66,000 | 505,000 | -300,000 | 88,000 | -197,000 | 38,000 | -33,000 | 191,000 | -190,000 | 7,000 | ||||||
deferred revenue | 1,431,000 | -676,000 | -863,000 | 1,147,000 | 205,000 | -2,936,000 | 1,727,000 | 899,000 | 335,000 | -5,997,000 | 3,294,000 | ||||||||||||||||||||||||||||||||||||||||||||||
operating lease liabilities | -139,000 | -482,000 | -215,000 | -229,000 | 8,000 | -273,000 | -205,000 | -166,000 | -168,000 | -61,000 | -28,000 | ||||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | 0 | -4,000 | 10,000 | -16,000 | -32,000 | -19,000 | 2,000 | -4,000 | 6,000 | -8,000 | 20,000 | -1,000 | 5,000 | 2,000 | 2,000 | -12,000 | 7,000 | 8,000 | 3,000 | -13,000 | 2,000 | 0 | 1,000 | -21,000 | 15,000 | 1,000 | 3,000 | -20,000 | -9,000 | 14,000 | 4,000 | -23,000 | 4,000 | 11,000 | -20,000 | -21,000 | 2,000 | 23,000 | -2,000 | -16,000 | -34,000 | 11,000 | -2,000 | -36,000 | 57,000 | 17,000 | -53,000 | ||||||||||
net cash from operating activities | -3,689,000 | -1,171,000 | -282,000 | -2,302,000 | -1,605,000 | -5,873,000 | 2,380,000 | 1,224,000 | -2,824,000 | -545,000 | 3,901,000 | 5,868,000 | -1,123,000 | -195,000 | 5,461,000 | -767,000 | -2,936,000 | 3,337,000 | 1,874,000 | -190,000 | -256,000 | -2,898,000 | 643,000 | -1,384,000 | -364,000 | -86,000 | -190,000 | -844,000 | -1,836,000 | -1,986,000 | -971,000 | 1,745,000 | -943,000 | 1,724,000 | -3,877,000 | -27,000 | -3,052,000 | -1,574,000 | -854,000 | -1,757,000 | -2,096,000 | -616,000 | -797,000 | -625,000 | -218,000 | -604,000 | 263,000 | 172,000 | |||||||||
capital expenditures | -74,000 | -467,000 | -1,391,000 | -2,818,000 | -1,656,000 | -321,000 | -197,000 | -46,000 | -263,000 | -156,000 | -284,000 | -1,184,000 | -79,000 | -15,000 | -84,000 | -198,000 | -86,000 | -73,000 | -59,000 | -22,000 | -11,000 | -147,000 | -47,000 | -12,000 | -28,000 | -73,000 | -50,000 | -49,000 | -21,000 | -19,000 | -84,000 | -114,000 | -145,000 | -129,000 | -184,000 | -258,000 | -131,000 | -29,000 | -721,000 | -148,000 | -21,000 | -12,000 | -1,000 | -84,000 | -21,000 | 0 | -46,000 | -6,000 | |||||||||
free cash flows | -3,763,000 | -1,638,000 | -1,673,000 | -5,120,000 | -3,261,000 | -6,194,000 | 2,183,000 | 1,178,000 | -3,087,000 | -701,000 | 3,617,000 | 4,684,000 | -1,202,000 | -210,000 | 5,377,000 | -965,000 | -3,022,000 | 3,264,000 | 1,815,000 | -212,000 | -267,000 | -3,045,000 | 596,000 | -1,396,000 | -392,000 | -159,000 | -240,000 | -893,000 | -1,857,000 | -2,005,000 | -1,055,000 | 1,631,000 | -1,088,000 | 1,595,000 | -4,061,000 | -285,000 | -3,183,000 | -1,603,000 | -1,575,000 | -1,905,000 | -2,117,000 | -628,000 | -798,000 | -709,000 | -239,000 | -604,000 | 217,000 | 166,000 | |||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -74,000 | -467,000 | -1,391,000 | -2,818,000 | -1,656,000 | -321,000 | -197,000 | -46,000 | -263,000 | -156,000 | -284,000 | -1,184,000 | -79,000 | -15,000 | -84,000 | -198,000 | -86,000 | -73,000 | -59,000 | -22,000 | -11,000 | -147,000 | -47,000 | -12,000 | -28,000 | -73,000 | -50,000 | -49,000 | -21,000 | -19,000 | -84,000 | -114,000 | -145,000 | -129,000 | -184,000 | -258,000 | -131,000 | -67,000 | -21,000 | -29,000 | -721,000 | -148,000 | -21,000 | -12,000 | -1,000 | -84,000 | -21,000 | -185,000 | |||||||||
payments for business acquisition, net of cash and cash equivalents acquired | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -74,000 | -2,268,000 | -1,391,000 | -2,818,000 | -2,116,000 | -321,000 | -10,812,000 | -46,000 | -263,000 | -156,000 | 17,716,000 | 6,816,000 | -7,721,000 | -17,667,000 | -84,000 | -198,000 | -86,000 | -73,000 | -59,000 | -22,000 | -11,000 | -147,000 | -47,000 | -14,000 | -26,000 | -73,000 | -50,000 | -49,000 | -21,000 | -19,000 | -84,000 | 5,851,000 | -138,000 | -6,101,000 | -184,000 | -258,000 | -131,000 | -67,000 | -21,000 | -29,000 | -721,000 | -148,000 | -21,000 | -12,000 | -1,000 | -84,000 | -21,000 | -52,000 | -46,000 | -6,000 | |||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock from public offering, net of issuance costs | 10,224,000 | -33,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under employee plans | 58,000 | 897,000 | 170,000 | 515,000 | 63,000 | 775,000 | 56,000 | 537,000 | 178,000 | 774,000 | 318,000 | 597,000 | 853,000 | 657,000 | 455,000 | 52,000 | 0 | 237,000 | 223,000 | 302,000 | 38,000 | ||||||||||||||||||||||||||||||||||||
shares repurchased for tax withholdings on vesting of restricted stock units | -454,000 | -491,000 | -328,000 | -177,000 | -181,000 | -162,000 | -116,000 | -20,000 | -448,000 | -1,012,000 | -380,000 | -464,000 | -37,000 | -1,179,000 | |||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | 9,828,000 | 9,777,000 | -158,000 | 251,000 | -114,000 | 594,000 | -106,000 | 421,000 | 158,000 | 254,000 | -694,000 | 184,000 | 7,242,000 | 620,000 | -724,000 | 361,000 | 26,000 | 25,239,000 | 135,000 | 77,000 | 1,518,000 | 175,000 | 190,000 | 1,749,000 | 130,000 | 231,000 | 62,000 | -5,986,000 | 123,000 | 203,000 | 109,000 | 198,000 | 126,000 | 367,000 | 234,000 | 16,026,000 | 47,000 | 5,668,000 | 94,000 | 46,000 | 2,000,000 | 237,000 | 223,000 | 3,947,000 | -489,000 | 2,416,000 | 538,000 | 9,000 | -107,000 | -95,000 | |||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | 11,000 | -11,000 | 9,000 | -12,000 | 28,000 | -12,000 | 9,000 | -21,000 | -4,000 | 6,000 | -22,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 6,076,000 | -4,881,000 | -3,807,000 | -5,612,000 | -8,529,000 | 1,578,000 | -2,933,000 | -441,000 | 20,901,000 | 12,866,000 | -1,616,000 | -17,273,000 | 4,663,000 | 28,501,000 | 1,948,000 | 880,000 | |||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 26,480,000 | 0 | 0 | 49,309,000 | 0 | 0 | 30,204,000 | 0 | 0 | 31,564,000 | 0 | 0 | 4,662,000 | 0 | 0 | 5,513,000 | 0 | 0 | 5,508,000 | ||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | 6,076,000 | 6,327,000 | 24,658,000 | -3,807,000 | -5,612,000 | 40,780,000 | -2,933,000 | -441,000 | 51,105,000 | -1,616,000 | -17,273,000 | 36,227,000 | -3,011,000 | 28,501,000 | 6,610,000 | 6,393,000 | -244,000 | 36,000 | 5,346,000 | ||||||||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net transfer of equipment between inventory and property and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 532,000 | 1,576,000 | -181,000 | -1,891,000 | -2,221,000 | -719,000 | -275,000 | 1,645,000 | -2,335,000 | 90,000 | -210,000 | -201,000 | 80,000 | 194,000 | -70,000 | 19,000 | 4,000 | 532,000 | -46,000 | -1,089,000 | -86,000 | -52,000 | |||||||||||||||||||||||||||||||||||
net income | -2,084,000 | -2,899,000 | -643,000 | -1,028,000 | 660,000 | 23,864,000 | -1,471,000 | 6,089,000 | 4,674,000 | 6,111,000 | 4,132,000 | 3,725,000 | 589,000 | 5,794,000 | 2,243,000 | 717,000 | 696,000 | 107,000 | -2,885,000 | 110,000 | -3,201,000 | -629,000 | -1,515,000 | 191,000 | 267,000 | 60,000 | 10,000 | -755,000 | 294,000 | -1,900,000 | 239,000 | -296,000 | |||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -1,822,000 | 36,000 | -162,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accretion of investment discount | 0 | 0 | 0 | -130,000 | -271,000 | -241,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
provision for credit losses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for business acquisition, net of cash and cash equivalent acquired | 0 | -460,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities of investments | 0 | 0 | 0 | 18,000,000 | 8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of investments | 0 | -15,642,000 | 7,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares repurchased for tax withholdings on vesting of restricted stock units and in connection with the termination of the esop | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment included in accounts payable and accrued liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | -10,615,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain from forgiveness of ppp loan | 0 | 0 | 0 | -1,698,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit repayments | 0 | -1,400,000 | -115,000 | -527,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | 0 | 0 | 31,000 | 4,000 | -8,000 | 20,000 | -20,000 | 25,000 | -17,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
issuance cost of common stock offering | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash lease expenses | 172,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash operating lease expense | 78,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain from dissolution of aehr test systems japan | 0 | 0 | 0 | -2,186,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit related to dissolution of aehr test systems japan | 0 | 0 | 0 | -215,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
trade and other accounts receivable | -5,202,000 | -1,204,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other | 43,000 | 105,000 | 62,000 | -201,000 | 163,000 | -74,000 | -9,000 | -46,000 | 72,000 | 23,000 | 35,000 | -181,000 | 4,000 | 182,000 | -66,000 | -127,000 | 48,000 | -30,000 | |||||||||||||||||||||||||||||||||||||||
customer deposits and deferred revenue | 2,002,000 | -2,854,000 | 366,000 | 855,000 | -3,803,000 | -3,971,000 | 6,829,000 | 3,141,000 | -379,000 | 592,000 | -331,000 | 214,000 | -227,000 | -1,454,000 | 1,145,000 | -1,006,000 | 227,000 | -813,000 | -378,000 | 609,000 | -718,000 | -586,000 | 262,000 | -440,000 | 2,527,000 | -58,000 | -1,685,000 | 946,000 | -312,000 | 731,000 | -524,000 | -2,804,000 | 3,039,000 | 920,000 | 37,000 | -294,000 | -293,000 | -707,000 | -393,000 | 409,000 | |||||||||||||||||
other long-term liabilities | 4,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit (repayments) borrowings | 0 | -471,000 | -154,000 | -114,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash, cash equivalents and restricted cash | -2,000 | -14,000 | -31,000 | 10,000 | 68,000 | -15,000 | -2,000 | -2,000 | 38,000 | 6,000 | 94,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash paid during the year for: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of property plant equipment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards | 26,000 | 1,209,000 | 1,535,000 | 118,000 | 175,000 | 190,000 | 130,000 | 231,000 | 62,000 | 203,000 | 109,000 | 126,000 | 47,000 | ||||||||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalent and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery of doubtful accounts | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of assets | 9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred rent | 2,000 | 4,000 | 2,000 | 82,000 | 0 | 0 | 0 | -8,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
repayment of convertible notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit borrowings | 0 | 233,000 | 44,000 | 692,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash, cash equivalents and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of fixed asset | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of property and equipment | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalent and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
transfers of property and equipment to inventories | 0 | 372,000 | 372,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: stock-based compensation expense | 270,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash and cash equivalents | 16,000 | -36,000 | 16,000 | 7,000 | 32,000 | -60,000 | -38,000 | -23,000 | 73,000 | -24,000 | 17,000 | 23,000 | 21,000 | -129,000 | 86,000 | ||||||||||||||||||||||||||||||||||||||||||
(recovery of) provision for doubtful accounts | -55,000 | 11,000 | 14,000 | -13,000 | -11,000 | -20,000 | -1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance costs | 44,000 | 45,000 | 44,000 | 51,000 | 44,000 | 45,000 | 37,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under public offering, net of issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under private placement, net of issuance costs | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 7,771,000 | -882,000 | -4,034,000 | -3,810,000 | 15,764,000 | -3,115,000 | -1,533,000 | 517,000 | -1,698,000 | -1,874,000 | 3,253,000 | 266,000 | 59,000 | 111,000 | |||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value of common stock issued to settle accounts payable | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash used in operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -1,702,000 | -1,862,000 | -984,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 16,848,000 | 0 | 0 | 17,803,000 | 0 | 0 | 939,000 | 0 | 0 | 5,527,000 | 0 | 0 | 1,809,000 | 0 | 0 | 2,324,000 | 0 | 0 | 2,073,000 | 0 | |||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of period | -1,702,000 | -1,862,000 | 15,864,000 | -882,000 | -4,034,000 | 13,993,000 | -3,115,000 | 2,812,000 | 2,342,000 | 517,000 | -1,698,000 | 3,653,000 | -1,322,000 | 1,521,000 | 2,075,000 | -648,000 | 59,000 | 2,435,000 | 189,000 | -709,000 | 1,901,000 | -151,000 | |||||||||||||||||||||||||||||||||||
loss on disposal of asset | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit borrowings (repayments) | 0 | 223,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of convertible notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in capitalized stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit converted to convertible notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards | 234,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair value of common stock issued to settle accounts payable | 323,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision (recovery of) for doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issuance cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 1,244,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards | 94,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 1,403,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in capitalized share-based compensation | -20,000 | -7,000 | -42,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
(recovery of) benefit from doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of asset | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock under private placement, net of issuance cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash transactions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for (recovery of) doubtful accounts | -9,000 | -2,000 | 19,000 | 7,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash | 92,000 | -30,000 | 20,000 | -35,000 | -186,000 | -33,000 | -1,000 | -51,000 | 40,000 | -162,000 | -93,000 | 5,000 | -78,000 | ||||||||||||||||||||||||||||||||||||||||||||
proceed from issuance of long-term debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash andcash equivalents | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock and exercise of stock options | 315,000 | 79,000 | 364,000 | 59,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
used in operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of long-term investment | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payable | -30,000 | 12,000 | -2,000 | -45,000 | -20,000 | 1,000 | 13,000 | 1,000 | -34,000 | 11,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash from | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating activities | -957,000 | -272,000 | -1,669,000 | -787,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investing activities. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
under private placement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
under employee plans | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
financing activities | 346,000 | 111,000 | 746,000 | 716,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash equivalents | -709,000 | -172,000 | 1,067,000 | -151,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non cash transactions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred lease commitment | -24,000 | -24,000 | -23,000 | -19,000 | -16,000 | -14,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment | -46,000 | -6,000 | -1,000 | -105,000 | -5,000 | -16,000 | -25,000 | -2,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of investments | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
investing activities | -5,000 | -16,000 | -25,000 | -2,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses and deferred revenue | -289,000 | 224,000 | 16,000 | 569,000 | -425,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred lease commitment, net of current | -19,000 | -18,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
and exercise of stock options | 113,000 | 67,000 | 54,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation expense | 169,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock compensation expense | 182,000 |